FR23C1045I1 - Composition pour l'utilisation chronique comme composé de prise de poids - Google Patents
Composition pour l'utilisation chronique comme composé de prise de poidsInfo
- Publication number
- FR23C1045I1 FR23C1045I1 FR23C1045C FR23C1045C FR23C1045I1 FR 23C1045 I1 FR23C1045 I1 FR 23C1045I1 FR 23C1045 C FR23C1045 C FR 23C1045C FR 23C1045 C FR23C1045 C FR 23C1045C FR 23C1045 I1 FR23C1045 I1 FR 23C1045I1
- Authority
- FR
- France
- Prior art keywords
- composition
- weight gain
- chronic use
- compound
- gain compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001684 chronic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000004584 weight gain Effects 0.000 title 1
- 235000019786 weight gain Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/61—Growth hormones [GH] (Somatotropin)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/805—Pet food for dog, cat, bird, or fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562108902P | 2015-01-28 | 2015-01-28 | |
| PCT/US2016/015150 WO2016123233A1 (fr) | 2015-01-28 | 2016-01-27 | Compositions et procédés pour l'utilisation chronique de composé de prise de poids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR23C1045I1 true FR23C1045I1 (fr) | 2024-01-12 |
Family
ID=56433115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR23C1045C Active FR23C1045I1 (fr) | 2015-01-28 | 2023-11-28 | Composition pour l'utilisation chronique comme composé de prise de poids |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9700591B2 (fr) |
| EP (1) | EP3250203B1 (fr) |
| JP (2) | JP6467513B2 (fr) |
| KR (3) | KR20170097212A (fr) |
| CN (2) | CN107205991A (fr) |
| AR (1) | AR103555A1 (fr) |
| AU (1) | AU2016211520B2 (fr) |
| BR (1) | BR112017016078A2 (fr) |
| CA (1) | CA2974012C (fr) |
| ES (1) | ES2902795T3 (fr) |
| FR (1) | FR23C1045I1 (fr) |
| MX (1) | MX2017009435A (fr) |
| NL (1) | NL301251I2 (fr) |
| NO (1) | NO2023044I1 (fr) |
| NZ (2) | NZ733658A (fr) |
| PL (1) | PL3250203T3 (fr) |
| PT (1) | PT3250203T (fr) |
| RU (1) | RU2680410C1 (fr) |
| TW (2) | TWI731241B (fr) |
| WO (1) | WO2016123233A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3037368A1 (fr) * | 2016-11-11 | 2018-05-17 | Hill's Pet Nutrition, Inc. | Nourriture pour animaux de compagnie comprenant du steviol |
| US11432776B2 (en) * | 2019-06-13 | 2022-09-06 | International Business Machines Corporation | Medical device administration and interaction |
| WO2024173199A1 (fr) * | 2023-02-13 | 2024-08-22 | Myos Corp. | Traitement pour maladie rénale chronique |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2095786A1 (fr) | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Methode de stimulation de l'appetit |
| EP1181933A3 (fr) | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Utilisation d'un secretagogue de l'hormone de croissance comme comme inducteur de la faim |
| US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| AU2006310690B2 (en) | 2005-11-02 | 2012-05-31 | Société des Produits Nestlé S.A. | Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| CN101541341B (zh) | 2006-09-27 | 2013-06-05 | 益普生制药两合公司 | N末端取代的生长素释放肽类似物 |
| BRPI0807046A2 (pt) * | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
| TWI429436B (zh) | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| GEP20156222B (en) | 2009-03-26 | 2015-01-26 | Takeda Pharmaceutical | Pyrazole compound |
| CA2789750C (fr) * | 2010-02-26 | 2018-03-06 | Raqualia Pharma Inc. | Agoniste de recepteur de ghreline pour le traitement de la dyscrasie |
| RU2648958C2 (ru) * | 2012-09-27 | 2018-03-28 | Аратана Терапьютикс, Инк. | Композиции и способы применения соединения для борьбы с отсутствием аппетита |
| EP2988616B1 (fr) * | 2013-03-15 | 2018-10-17 | Mars, Incorporated | Traitement de vomissement idiopathique chronique chez des félins et des chiens |
-
2016
- 2016-01-27 JP JP2017540234A patent/JP6467513B2/ja active Active
- 2016-01-27 NZ NZ733658A patent/NZ733658A/en unknown
- 2016-01-27 RU RU2017128087A patent/RU2680410C1/ru active
- 2016-01-27 KR KR1020177021599A patent/KR20170097212A/ko active Application Filing
- 2016-01-27 KR KR1020187035176A patent/KR102256847B1/ko active IP Right Grant
- 2016-01-27 PL PL16744044T patent/PL3250203T3/pl unknown
- 2016-01-27 CN CN201680007537.8A patent/CN107205991A/zh active Pending
- 2016-01-27 CN CN201811346148.5A patent/CN109200268A/zh active Pending
- 2016-01-27 EP EP16744044.5A patent/EP3250203B1/fr active Active
- 2016-01-27 ES ES16744044T patent/ES2902795T3/es active Active
- 2016-01-27 KR KR1020187027818A patent/KR20180108916A/ko not_active Application Discontinuation
- 2016-01-27 WO PCT/US2016/015150 patent/WO2016123233A1/fr active Application Filing
- 2016-01-27 CA CA2974012A patent/CA2974012C/fr active Active
- 2016-01-27 PT PT167440445T patent/PT3250203T/pt unknown
- 2016-01-27 AU AU2016211520A patent/AU2016211520B2/en active Active
- 2016-01-27 US US15/007,525 patent/US9700591B2/en active Active
- 2016-01-27 MX MX2017009435A patent/MX2017009435A/es unknown
- 2016-01-27 BR BR112017016078A patent/BR112017016078A2/pt not_active Application Discontinuation
- 2016-01-27 NZ NZ742808A patent/NZ742808A/en unknown
- 2016-01-28 TW TW107115943A patent/TWI731241B/zh active
- 2016-01-28 AR ARP160100245A patent/AR103555A1/es unknown
- 2016-01-28 TW TW105102744A patent/TWI674896B/zh active
-
2017
- 2017-05-22 US US15/601,240 patent/US10064909B2/en active Active
-
2018
- 2018-10-12 JP JP2018193722A patent/JP7120718B2/ja active Active
-
2023
- 2023-11-21 NL NL301251C patent/NL301251I2/nl unknown
- 2023-11-28 FR FR23C1045C patent/FR23C1045I1/fr active Active
- 2023-12-05 NO NO2023044C patent/NO2023044I1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269232B (en) | Fungicides | |
| SG11202103810VA (en) | Substituted tolyl as fungicides | |
| ZA201707424B (en) | Novel 5-substituted imidazole derivatives | |
| IL247276A0 (en) | [1,2,4]-converted triazole and imidazole compounds as fungicides | |
| HUE049099T2 (hu) | Fungicid hatású készítmények | |
| MA42599A (fr) | Dérivés de triazole, leurs intermédiaires et leur utilisation comme fongicides | |
| FR23C1045I1 (fr) | Composition pour l'utilisation chronique comme composé de prise de poids | |
| DK3240416T3 (da) | Fungicide sammensætninger | |
| CL2016003145A1 (es) | Compuestos de [1,2,4]triazol sustituido | |
| IL271604B (en) | Fungicides | |
| PL3154949T3 (pl) | PODSTAWIONE ZWIĄZKI [1,2,4]TRIAZOLOWE i IMIDAZOLOWE JAKO FUNGICYDY | |
| HK1247788A1 (zh) | 殺真菌化合物和組合物 | |
| ZA201608472B (en) | Substituted [1,2,4]triazole and imidazole compounds as fungicides | |
| PL3724282T3 (pl) | Kompozycje zawierające polioksazolinę katalizowane solą oniową | |
| IL267893B (en) | Thiobenzoimidazole as fungicides | |
| HRP20190286T1 (hr) | Postupci za pripremu spojeva, kao što su 3-arilbutanali, korisni u sintezi medetomidina | |
| HK1221463A1 (zh) | 可用作 抑制劑的新型化合物 | |
| PT3337322T (pt) | Composições fungicidas | |
| IL265578A (en) | 5-substituted imidazolylmethyldioxolane derivatives as fungicides | |
| IL265638A (en) | 5-substituted imidazolylmethyloxirane derivatives as fungicides | |
| PT3462873T (pt) | Composições fungicidas | |
| FR3033711B3 (fr) | Structure d'assemblage pour piste-jouet | |
| MC200163B1 (fr) | Revêtement pour la protection des supports métalliques | |
| PL3604201T3 (pl) | Hydrauliczne oznaczanie masy | |
| ZA201701960B (en) | Fungicidal composition |